Investor Presentaiton slide image

Investor Presentaiton

DNA Low cost capital structure Weighted average cost of debt: 1.34% (Q3/2018: 1.62%) Maturity Nominal Amount EUR million Book Value EUR million Cost of Debt Unsecured € Bond 1.375% Mar-2025 250 242 1.43% Coupon Unsecured € Bond 2.875% Mar-2021 60 60 2.93% Coupon Bank Loans and Commercial Paper Total 40 100 100 0.17% 410 402 1.34% Cash & Cash Equivalents -23 Net Debt Net Debt/EBITDA1 In March 2018, DNA got a long-term credit rating Assigned Rating Outlook BBB (S&P) Stable 379 1.34 Notes 1. Defined as net debt divided by comparable EBITDA from the beginning of year (adjusted), excluding IFRS 15 impact DNA's Investor presentation, February 2019 Debt maturity schedule, EUR million EUR 150 million fully undrawn RCF providing additional liquidity and financial flexibility 68 258 250 60 4 8 60 8 8 8 2019 2020 2021 2022 2023 2024 2025 ■Bank Loans ■Bonds 30
View entire presentation